Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...
IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. Use this policy to establish a set of best practices for the issuance, management, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback